Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Isonics Corp. ISON -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (832)	4/22/1999 8:13:00 AM
From: GARY P GROBBEL	Respond to of 1099

If you don't buy it here in the 1.50/1.56 range you may not see this price level again...this on wires this morning: (COMTEX) B: PARTNERSHIP TO EXPLORE LOW COST ISOTOPE PRODUCTION FOR SE B: PARTNERSHIP TO EXPLORE LOW COST ISOTOPE PRODUCTION FOR SEMICONDUCTORS; Isonics Corporation Announces Research and Development Agreement With Silex GOLDEN, Colo., April 22 /PRNewswire/ -- Isonics Corporation (OTC Bulletin Board: ISON) announced today that it has signed a joint research and development agreement with Silex Systems Limited of North Ryde, New South Wales, Australia to collaborate on new technologies for the development of isotopically pure silicon for the semiconductor industry. The agreement calls for Isonics to provide Silex data from Isonics' silicon-28 wafer development program. These data will be used to enable Silex to assess the feasibility of building an isotope separation facility using the Silex laser separation technology. Silex has agreed to contribute $200,000 over the next 12 to 18 months to Isonics' planned development program, which will make bulk silicon-28 samples for evaluation by semiconductor device manufacturers. Isonics Vice President, Semiconductor Materials Dr. Stephen J. Burden commented, "Silex' substantial investment indicates their high level of confidence in their isotope separation technology. Isonics will provide the technical and economic information necessary to allow them to plan the establishment of a major isotope separation facility for the production of isotopically pure silicon. Silex is confident that its technology has the potential to produce silicon-28 significantly cheaper than any other isotope separation methods currently being used or in development. If they can achieve this, silicon-28 wafers can capture a much greater portion of the silicon wafer market than we had previously envisioned." On April 12, Isonics announced that it had entered into an licensing agreement with Yale University that entitles the Company to exclusive intellectual property rights to patents covering semiconductor devices derived from isotopically engineered materials. These patents cover silicon, germanium, gallium arsenide and most other isotopically pure semiconductors and are the basis for Isonics' silicon-28 wafer development and commercialization. Silex Systems has licensed its technology for uranium enrichment to the U.S. Enrichment Corporation (NYSE: USU), but has retained the right to use the technology for stable isotope separation. Silex is traded on the Australian stock exchange under the symbol SLX. Silex's web site is located at www.silex.com.au. Isonics is an advanced materials and technology company which develops and commercializes products based on enriched stable isotopes. Stable isotopes can be thought of as ultra-ultra pure materials. This high degree of purification provides enhanced performance properties compared to normal materials. Stable isotopes have commercial uses in several areas, including energy; research, medical diagnostics, and drug development; product tagging and stewardship; semiconductors; lasers; and optical materials. For more information, visit Isonics' web site at www.isonics.com. Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 1998 filed with the Securities and Exchange Commission. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. SOURCE Isonics Corporation -0- 04/22/99 /CONTACT: Matt Clawson of Allen & Caron, Inc., 714-957-8440, for Isonics Corporation; or Dr. Stephen J. Burden of Isonics Corporation, 303-279-7900/ /Web site: silex.com.au /Web site: isonics.com (ISON USU) CO: Isonics Corporation; Silex Systems Limited; U.S. Enrichment Corporation; Yale University ST: Colorado, Australia IN: CHM CPR MTC SU: JVN LIC * end of story *